Bristol-Myers Squibb

Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
earnings
biotech
Biogen
Alexion Pharmaceuticals
Bristol-Myers Squibb
Celgene
Gilead Sciences
Merck
Biomarin
Galapagos
Seattle Genetics
Dr Reddy's
Flag link:
FDA, EMA delay review of Opdivo/Yervoy for first-line NSCLC
FDA, EMA delay review of Opdivo/Yervoy for first-line NSCLC
BioCentury
Bristol-Myers Squibb
Opdivo
FDA
EMA
Yervoy
non-small cell lung cancer
Flag link:
Real threat to Opdivo’s small-cell chances will come from elsewhere
Real threat to Opdivo’s small-cell chances will come from elsewhere
EP Vantage
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
FDA
Tecentriq
Roche
Flag link:
Stada and Mylan targeting Bristol-Myers Squibb’s Upsa (€1bn)
Stada and Mylan targeting Bristol-Myers Squibb’s Upsa (€1bn)
GoinPharma
Stada
OTC
Upsa
Bristol-Myers Squibb
Flag link:
Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer
Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer
CP Wire
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
clinical trials
Flag link:
Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
Flag link:
Bristol-Myers to invest in Compugen, collaborate in clinical trials
Bristol-Myers to invest in Compugen, collaborate in clinical trials
Yahoo/Reuters
Bristol-Myers Squibb
CompuGen
clinical trials
solid tumors
COM701
Opdivo
Flag link:
Did Bristol-Myers Squibb Make a Huge Mistake With Nektar?
Did Bristol-Myers Squibb Make a Huge Mistake With Nektar?
Motley Fool
Bristol-Myers Squibb
Nektar Therapeutics
NKTR-2014
Flag link:
Just-Announced U.S. and Cuba Biopharma Venture Sees Fruit in Lung Cancer Study
Just-Announced U.S. and Cuba Biopharma Venture Sees Fruit in Lung Cancer Study
BioSpace
Cuba
Bristol-Myers Squibb
Opdivdo
lung cancer
Flag link:
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Fierce Pharma
drug pricing
China
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Flag link:
Bristol-Myers Squibb’s Psoriasis Drug Dazzles in Phase II Clinical Trial
Bristol-Myers Squibb’s Psoriasis Drug Dazzles in Phase II Clinical Trial
BioSpace
Bristol-Myers Squibb
BMS-986165
psoriasis
clinical trials
Flag link:
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
CP Wire
Bristol-Myers Squibb
Sprycel
acute lymphoblastic leukemia
FDA
Flag link:
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
Bristol-Myers Squibb
Sprycel
acute lymphoblastic leukemia
Flag link:
Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review
Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review
Yahoo/Zacks.com
Bristol-Myers Squibb
Empliciti
Celgene
Pomalyst
Multiple Myeloma
Flag link:
Immunotherapy Drugs Slow Skin Cancer That Has Spread to the Brain
Immunotherapy Drugs Slow Skin Cancer That Has Spread to the Brain
New York Times, NY
melanoma
Opdivo
clinical trials
Bristol-Myers Squibb
Flag link:
Bristol-Myers will sell Opdivo in China at half of US cost, setting precedent for checkpoint wave — report
Bristol-Myers will sell Opdivo in China at half of US cost, setting precedent for checkpoint wave — report
Endpoints
Bristol-Myers Squibb
China
Opdivo
drug pricing
Flag link:
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer
Xconomy
FDA
Opdivo
Bristol-Myers Squibb
small cell lung cancer
Flag link:
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
CP Wire
Clovis Oncology
clinical trials
Bristol-Myers Squibb
Opdivo
ovarian cancer
Flag link:
Did a blockbuster drug make hundreds gamble compulsively? A legal fight may decide what science can’t confirm
Did a blockbuster drug make hundreds gamble compulsively? A legal fight may decide what science can’t confirm
Stat
Abilify
compulsive behavior
Bristol-Myers Squibb
Otsuka
Flag link:
Opdivo Approved in Europe for Additional Use in Melanoma Patients
Opdivo Approved in Europe for Additional Use in Melanoma Patients
CP Wire
Opdivdo
Bristol-Myers Squibb
melanoma
advanced melanoma
Europe
Flag link:

Pages